DEC 02, 2016 5:30 AM PST

Early Skin Cancer May be Treatable with New Topical Cream

WRITTEN BY: Xuan Pham
Good news for patients with early stage skin cancer: a combination drug seems to be effective at attacking the skin cancer cells. And on top of that, the drug combo can be applied topically. Furthermore, because the drugs have already been approved and prescribed for years, thiscould significantly shorten the time before this new drug combo makes it to the market.


The drug is a combination of 5-fluorouracil, a common chemotherapy drug, and calcipotriol, a synthetic version of vitamin D. Both drugs are already approved for the treatment of skin-related conditions: 5-fluorouracil is prescribed for patients with actinic keratinosis, and calcipotriol treats psoriasis.
 
But together is better. In a trial, researchers found that the combination drug reduced the number of precancerous lesions on the face by 88 percent. By contrast, chemotherapy alone showed only a 26 percent reduction.
 
Of note, the drug is effective against early skin cancer known as actinic keratinosis. Untreated, this type of precancer evolves into squamous cell carcinoma, a fully dangerous skin cancer.
 
"We looked at precancerous lesions on patients with sun-damaged skin," said Washington University dermatologist and study co-author Lynn A. Cornelius, MD, director of the Division of Dermatology. "Most commonly found on the face, scalp and arms, these lesions appear abnormal by visual examination and under the microscope but are not full-blown skin cancers. But because these lesions have the potential to develop into a true skin cancer, they are commonly treated. Our study shows this combination therapy is more effective and better tolerated than current treatment practices."
 
The ease of application for this new chemo combo is unparalleled. The cream, applied topically on the skin, appears to boost the immune response. This sends more T cells to attack the abnormal cells at the precancerous lesions.
 

"The idea behind this study was to induce a heightened immune response in the skin using calcipotriol combined with the 5-fluorouracil that works to destroy the precancerous cells," Cornelius said. "In so doing, the destroyed precancerous cells release cell proteins, or antigens, and facilitate the heightened immune system to respond. We compared the two-drug formulation to 5-fluorouracil alone over a shorter application period -- four days as opposed to two to four weeks that is typical for the standard treatment of 5-fluorouracil alone."
 
"Because calcipotriol has been shown to induce an immune response, we are now interested in seeing if the anti-tumor immunity of the activated T cells can be recalled later to help prevent both precancerous and cancerous skin lesions," Cornelius said. "We are now planning to re-contact our patients to determine whether there are differences in precancerous and skin cancer rates between the two treatment groups."

Additional source: Washington University in St. Louis
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
SEP 23, 2021
Drug Discovery & Development
The FDA approves the first and only oral treatment for a certain non-small cell lung cancer.
SEP 23, 2021
The FDA approves the first and only oral treatment for a certain non-small cell lung cancer.
Last week, the United States Food and Drug Administration (FDA) granted approval for the first oral therapy to ...
OCT 12, 2021
Immunology
Cancer Drug Helps Alzheimer's Mice Remember
OCT 12, 2021
Cancer Drug Helps Alzheimer's Mice Remember
What if a drug—specifically developed to treat one disease—had the potential to address other non-related co ...
NOV 09, 2021
Microbiology
Can This Cat Parasite Become a Tumor Treatment?
NOV 09, 2021
Can This Cat Parasite Become a Tumor Treatment?
You may have heard of Toxoplasma gondii because it is so common. Cats carry this parasite, and anyone that cleans a litt ...
DEC 09, 2021
Cancer
Inflammation: Naughty or Nice List?
DEC 09, 2021
Inflammation: Naughty or Nice List?
Aulus Cornelius Celsus, a Roman physician, first identified the four major characteristics of inflammation in the first ...
JAN 06, 2022
Immunology
Gene for Smelling Helps Cancer Cells Move to the Brain
JAN 06, 2022
Gene for Smelling Helps Cancer Cells Move to the Brain
From tasting a delicious meal to picking up pheromones, olfaction (or the sense of smell) involves a network of complex ...
JAN 17, 2022
Cancer
High Fiber Diet Provides a Helpful Boost to Melanoma Treatment
JAN 17, 2022
High Fiber Diet Provides a Helpful Boost to Melanoma Treatment
Immune checkpoint inhibitors (ICIs) have become a promising new treatment for advanced cancers, including melanoma. Immu ...
Loading Comments...